Chronic Kidney Disease Stage 3a Classification and Management

Understanding the Classification System

• A GFR of 50 mL/min/1.73 m² corresponds to Stage 3a chronic kidney disease, defined as moderately decreased kidney function with GFR between 45-59 mL/min/1.73 m², according to the KDIGO classification system 1, 2
• The KDIGO classification system subdivides Stage 3 CKD into two categories, Stage 3a and Stage 3b, because mortality and adverse outcome risks differ substantially between these subgroups 1, 2

Cardiovascular and Progression Risk at This Stage

• Patients with Stage 3a CKD face a 2- to 4-fold increased cardiovascular risk compared to those without CKD 3

Immediate Clinical Actions Required

Medication Management

• Review and adjust all renally-cleared medications at a GFR level of 50 mL/min/1.73 m² 2
• Initiate ACE inhibitors or ARBs if the patient has diabetes with hypertension and any degree of albuminuria 2

Monitoring Requirements

• Annual monitoring minimum of both eGFR and urine albumin-to-creatinine ratio (UACR) for patients without elevated albuminuria 2
• More frequent monitoring (2-3 times yearly) if albuminuria is present 2

Therapeutic Targets to Achieve

• Blood pressure control (target ≤140/90 mmHg without albuminuria) 4
• Lifestyle modifications: sodium restriction, regular physical activity, smoking cessation, weight management 4

When to Refer to Nephrology

• Nephrology referral is recommended if severely increased albuminuria (A3 category, ≥300 mg/g) is present, regardless of GFR being in the 3a range 2
• Nephrology referral is not necessary for Stage 3a CKD with normal albuminuria and stable function 2, 4

Important Diagnostic Caveat

• The diagnosis of CKD requires abnormalities to be present for >3 months, so a single GFR measurement of 50 does not establish chronic kidney disease without confirmation 2